Exosomal miRNA-148a from CDCs improves TAC-induced myocardial hypertrophy via down-regulation of GP130, leading to the inhibition of STAT3/ERK1/2/AKT signaling pathway (141). Here, STAT3 is linked to cardiac hypertrophy.